BioTuesdays

Category - Feature

Feature

In conversation with Gagan Gill

By Len Zehr As CEO of closely-held SIGMA Surgical, an upstart data-analytics company, Gagan Gill has a passion for entrepreneurial adventure and startup culture. After stints in sales and marketing in the medical...

September 29, 2015
Feature

In conversation with Geoffrey Hamilton-Fairley

As CEO of closely-held Oncimmune, an early cancer diagnostic company in Britain, Geoffrey Hamilton-Fairley has had a personal commitment to cancer detection. His father was the first medical oncologist in the UK and an...

September 15, 2015
Feature

Hydra Biosciences to have Phase 1 TRPA1 data soon

By Len Zehr Closely-held Hydra Biosciences expects to complete Phase 1 trials of its HX-100 inhibitor of the Transient Receptor Potential (TRPA1) ion channel as a treatment for painful diabetic neuropathy and allergic...

September 1, 2015
Feature

Peritech readies U.S. launch of novel hemorrhoid gel

By Len Zehr Closely-held Peritech Pharma of Israel is in discussions with potential marketing partners for a U.S. launch of its once-daily over-the-counter gel, now known as PP-110, for the treatment of hemorrhoids. “PP...

August 24, 2015
Feature

Cellectar Biosciences refocusing on therapeutics

After completing a strategic review of its cancer therapeutic and cancer diagnostic assets, Cellectar Biosciences (NASDAQ:CLRB) has refocused the company on its phospholipid ether drug conjugate (PDC) platform and...

August 18, 2015
Feature

In conversation with Nicole Grannell

By Len Zehr As vice-president of business development for Bay Area Research Logistics (BARL), a specialized clinical trial design, packaging and logistics firm, Nicole Grannell manages the logistical components of...

August 4, 2015
Matinas BioPharma Holdings
Feature

Matinas BioPharma moves focus to anti-infectives

By Len Zehr After moving a novel omega-3 program through a successful Phase 2 program, Matinas BioPharma Holdings (OTCQB:MTNB) is now advancing two anti-infective drug candidates in the war against drug resistance. “Our...

July 28, 2015